86 related articles for article (PubMed ID: 23769090)
1. The significance of antiphospholipid antibodies in liver recipients.
Furmańczyk-Zawiska A; Tronina O; Baczkowska T; Chmura A; Durlik M
Transplant Proc; 2013 Jun; 45(5):1983-9. PubMed ID: 23769090
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in renal allograft recipients.
Furmańczyk-Zawiska A; Bączkowska T; Sadowska A; Szmidt J; Chmura A; Durlik M
Transplant Proc; 2013 May; 45(4):1655-60. PubMed ID: 23726642
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
5. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus.
García-Martín P; García-García C; Fraga J; García-Díez A
Actas Dermosifiliogr; 2013 Apr; 104(3):232-8. PubMed ID: 23332556
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
[TBL] [Abstract][Full Text] [Related]
8. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis--preliminary report.
Sulik A; Kowal-Bielecka O; Domysławska I; Chwiećko J; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():228-31. PubMed ID: 16119673
[TBL] [Abstract][Full Text] [Related]
12. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
15. Anti-β2-glycoprotein I antibodies are highly prevalent in a large number of Brazilian leprosy patients.
Ribeiro SL; Pereira HL; Silva NP; Souza AW; Sato EI
Acta Reumatol Port; 2011; 36(1):30-7. PubMed ID: 21483278
[TBL] [Abstract][Full Text] [Related]
16. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
19. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
[TBL] [Abstract][Full Text] [Related]
20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
